Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Pediatric Brain Tumor Consortium
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium
ClinicalTrials.gov Identifier:
NCT01964300
First received: October 14, 2013
Last updated: October 26, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)